本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Shattuck Labs, Inc.

4.00
+0.14003.63%
盤後3.95-0.0500-1.25%16:26 EST
成交量:27.63萬
成交額:111.41萬
市值:2.53億
市盈率:-4.10
高:4.22
開:3.83
低:3.83
收:3.86
52周最高:4.89
52周最低:0.6922
股本:6,327.98萬
流通股本:2,414.88萬
量比:1.00
換手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-0.9753
每股收益(LYR):-1.4857
淨資產收益率:-57.84%
總資產收益率:-33.93%
市淨率:2.71
市盈率(LYR):-2.69

資料載入中...

公司資料

公司名字:
Shattuck Labs, Inc.
交易所:
NASDAQ
成立時間:
2016
員工人數:
44
公司地址:
500 West 5th Street,Suite 1200,Austin,Texas,United States
郵編:
78701
電話:
傳真:
- -
簡介:
Shattuck Labs, Inc.於2016年5月9日在特拉華州成立。該公司是一家創新的臨床階段生物技術公司,致力於開發雙面融合蛋白作為一種全新的生物醫學產品。

董事

名稱
職位
George Golumbeski
Independent Chairman of the Board
Taylor Schreiber
Chief Executive Officer and Director
Clay Siegall
Independent Director
Daniel Baker
Independent Director
Helen M. Boudreau
Independent Director
Mona Ashiya
Independent Director
Neil Gibson
Independent Director

股東

名稱
職位
Taylor Schreiber
Chief Executive Officer and Director
Andrew R. Neill
Chief Financial Officer
Abhinav Shukla
Chief Technical Officer
Arunthathy Nirmalini Pandite
Chief Medical Officer
Casi DeYoung
Chief Business Officer
Stephen Stout
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer